VC  Exsight Capital

     Office Locations:

437 Madison Ave, 28th Floor
New York, NY 10022



  • Early



  • Life Sciences & Healthcare
  • Medical Device
  • Software & Internet



    Exsight Capital is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of two accomplished retinal surgeons and a team of investment professionals that have partnered to address the need for funding early stage ophthalmic focused companies. The firm seeks investments in biotechnology, medical devices, pharmaceuticals and software solutions in ophthalmology.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Adam Benowitz Partner
    Alan M. Spiro JD, PhD Partner
    Dr. Firas Rahhal Partner
    Dr. Michael Nissen Partner
    James C. Murray JD Partner


    Portfolio companies include:


    Recent News:

      There is no recent news for Exsight Capital.